The University of Chicago Header Logo

Connection

Christopher Salerno to Middle Aged

Back to Details
This is a "connection" page, showing publications Christopher Salerno has written about Middle Aged.
Christopher Salerno
Connection Strength
0.572
Middle Aged
  1. Opening the "Dor," Not Always an Inferior Approach. ASAIO J. 2019 07; 65(5):e50-e51.
    View in: PubMed
    Score: 0.046
  2. Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device. ASAIO J. 2018 Jul/Aug; 64(4):570-572.
    View in: PubMed
    Score: 0.043
  3. Impact of Center Left Ventricular Assist Device Volume on Outcomes After Implantation: An INTERMACS Analysis. JACC Heart Fail. 2017 10; 5(10):691-699.
    View in: PubMed
    Score: 0.041
  4. INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome. J Heart Lung Transplant. 2016 Apr; 35(4):440-8.
    View in: PubMed
    Score: 0.036
  5. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014 Aug; 33(8):809-15.
    View in: PubMed
    Score: 0.032
  6. [Comparison of the leukaemia incidence in two cohorts of farmers and traders in the Vercelli province of Italy, 2002-2009]. Ann Ig. 2011 Jan-Feb; 23(1):27-32.
    View in: PubMed
    Score: 0.026
  7. Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation? Eur J Cardiothorac Surg. 2007 Mar; 31(3):457-61.
    View in: PubMed
    Score: 0.020
  8. Open-chest management after heart transplantation. Tex Heart Inst J. 2006; 33(3):306-9.
    View in: PubMed
    Score: 0.018
  9. Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device. J Am Coll Cardiol. 2023 08 29; 82(9):771-781.
    View in: PubMed
    Score: 0.015
  10. The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
    View in: PubMed
    Score: 0.015
  11. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022 09 27; 328(12):1233-1242.
    View in: PubMed
    Score: 0.014
  12. Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: A retrospective multicenter study. J Thorac Cardiovasc Surg. 2022 06; 163(6):2107-2116.e6.
    View in: PubMed
    Score: 0.013
  13. The use of enoxaparin as bridge to therapeutic INR after LVAD implantation. J Cardiothorac Surg. 2020 Nov 14; 15(1):329.
    View in: PubMed
    Score: 0.013
  14. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2020 06; 39(6):529-537.
    View in: PubMed
    Score: 0.012
  15. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg. 1999 Jun; 117(6):1063-9.
    View in: PubMed
    Score: 0.012
  16. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
    View in: PubMed
    Score: 0.011
  17. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. Circulation. 2019 01 08; 139(2):155-168.
    View in: PubMed
    Score: 0.011
  18. Left Lateral Thoracotomy for Centrifugal Continuous-Flow Left Ventricular Assist Device Placement: An Analysis from the Mechanical Circulatory Support Research Network. ASAIO J. 2018 Nov/Dec; 64(6):715-720.
    View in: PubMed
    Score: 0.011
  19. Impact of Patient Distance From Ventricular Assist Device-Implanting Center on Short- and Long-Term Outcomes. ASAIO J. 2018 Nov/Dec; 64(6):721-726.
    View in: PubMed
    Score: 0.011
  20. Bleeding Complication Rates Are Higher in Females after Continuous-Flow Left Ventricular Assist Device Implantation. ASAIO J. 2018 Nov/Dec; 64(6):748-753.
    View in: PubMed
    Score: 0.011
  21. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 2018 10 30; 138(18):1923-1934.
    View in: PubMed
    Score: 0.011
  22. Primary esophageal lymphoma: a diagnostic challenge. Ann Thorac Surg. 1998 Oct; 66(4):1418-20.
    View in: PubMed
    Score: 0.011
  23. Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg. 1998 May; 65(5):1415-9.
    View in: PubMed
    Score: 0.011
  24. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
    View in: PubMed
    Score: 0.011
  25. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 01; 37(1):7-14.
    View in: PubMed
    Score: 0.010
  26. Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support. J Card Fail. 2017 Dec; 23(12):852-858.
    View in: PubMed
    Score: 0.010
  27. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
    View in: PubMed
    Score: 0.010
  28. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):440-450.
    View in: PubMed
    Score: 0.010
  29. Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes. J Card Fail. 2016 Dec; 22(12):981-987.
    View in: PubMed
    Score: 0.010
  30. Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device. Ann Thorac Surg. 2017 Jan; 103(1):106-112.
    View in: PubMed
    Score: 0.010
  31. The HeartMate II Risk Score: An Adjusted Score for Evaluation of All Continuous-Flow Left Ventricular Assist Devices. ASAIO J. 2016 May-Jun; 62(3):281-5.
    View in: PubMed
    Score: 0.009
  32. The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. JACC Heart Fail. 2015 Oct; 3(10):818-28.
    View in: PubMed
    Score: 0.009
  33. Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device. J Card Surg. 2015 Oct; 30(10):775-80.
    View in: PubMed
    Score: 0.009
  34. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):581-9; discussion 589.
    View in: PubMed
    Score: 0.008
  35. Characteristics of extracoronary vascular disease in heart transplant recipient. J Card Surg. 2008 Sep-Oct; 23(5):459-63.
    View in: PubMed
    Score: 0.005
  36. Successful management of asystole with an isolated left ventricular assist device. J Heart Lung Transplant. 2006 Apr; 25(4):490-2.
    View in: PubMed
    Score: 0.005
  37. Cardiac allograft aortic dissection: successful repair using a composite valve graft and modified-Cabrol coronary reconstruction. J Card Surg. 2005 Sep-Oct; 20(5):450-2.
    View in: PubMed
    Score: 0.004
  38. Pulmonary thromboembolectomy of donor lungs prior to lung transplantation. Ann Thorac Surg. 1999 Jun; 67(6):1787-9.
    View in: PubMed
    Score: 0.003
  39. Management of recurrent ventricular tachycardia with ventricular assist device placement. Ann Thorac Surg. 1998 Aug; 66(2):571-3.
    View in: PubMed
    Score: 0.003
  40. Risk of left ventricular assist device as a bridge to heart transplant following postinfarction ventricular septal rupture. J Card Surg. 1997 Mar-Apr; 12(2):93-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.